SNAP-8 Reference

Plain English

What it is

SNAP-8, also called acetyl octapeptide-3, is a lab-made skincare peptide. It is a slightly longer cousin of Argireline, built by adding to that ingredient, and it belongs to the same family meant to calm the tiny nerve signals that make expression lines. It is sold as a cosmetic ingredient, not as an approved medicine.

What people use it for

People put it in face serums, creams, and patches to try to soften fine lines and wrinkles, especially around the forehead and eyes. It is often combined with Argireline and Matrixyl in the same skincare products.

What the science shows

The published research is limited to small cosmetic-formulation studies looking at how it affects the look of skin, such as eye-area wrinkle patches. That is a much weaker evidence base than the studies behind systemic or injectable medicines, and much of the data comes from product testing.

The catch

This is a topical (on-the-skin) ingredient only and is not meant to be injected. There is no FDA-approved SNAP-8 drug. Using an injectable form falls outside any approved use and is not supported by published research.

Reference summary

Published evidence is limited to small cosmetic-formulation studies of topical anti-wrinkle effects. SNAP-8 is not the same evidence base as systemic / injectable peptides.

Regulatory and posture

Categories

Skin/Hair

Aliases

Acetyl octapeptide-3, SNAP-25 mimetic

Evidence posture

preclinical - Cosmetic / topical-grade peptide. Not a drug. Effects are documented in cosmetic-formulation studies only; not the same evidence base as systemic / injectable peptides.

Regulatory status

No FDA-approved SNAP-8 drug label. SNAP-8 is a cosmetic-grade topical peptide marketed as an Argireline-style SNAP25-mimetic in skincare formulations. It is not a drug.

Content review status

research reference

Related tools

• Injection-site rotation overview - Public overview of the Pro site-rotation planner.